Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting

Blood

Volumn 89, Issue 2, 1997, Pages 724-731

  Corradini, Paolo ^a,b   Astolfi, Monica ^a   Cherasco, Cristina ^a   Ladetto, Marco ^a   Voena, Claudia ^a   Caracciolo, Daniele ^a   Pileri, Alessandro ^a   Tarella, Corrado ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Dipto di Med e Oncol Sperimentale Div Universitaria di Ematologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY FORMING UNIT GM; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; MANTLE CELL LYMPHOMA; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0031015411     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.724     Document Type: Article

References (48)

1. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laporte JP, Maraninchi D, Pico J, Bosly A, Anderson C, Schots R, Biron P, Cabanillas F, Dicke K: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493, 1987
2. Takvorian T, Canellos G, Ritz J, Freedman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with poor prognosis. N Engl J Med 316:1499, 1987
3. Freedman AS, Takvorkian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Rits J, Nadler LM: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784, 1990
4. Peterson FB, Appelbaum FR, Hill R, Fisher LD, Bigelow CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP, Storb R, Clift RA, Fefer A, Press OW, Weiden PL, Siger J, Thomas ED, Buckner CD: Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle. J Clin Oncol 8:638, 1990
5. Caracciolo D, Gavarotti P, Aglietta M, Bondesan P, Falda M, Gallo E, Locatelli F, Novarino A, Paolino F, Sanavio F, Urgesi A, Vitolo U, Tarella C: High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 12:621, 1993
6. Vose JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage JO: High-dose chemotherapy an autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846, 1993
7. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van Der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540, 1995
8. Armitage JO: Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023, 1993
9. Longo D: What's the deal with follicular lymphomas? J Clin Oncol 11:202, 1993
10. Horning SJ: Treatment approaches to the low grade lymphomas. Blood 83:881, 1994
11. Shivdasani RA, Hess JL, Skarin AT, Pinkus GS: Intermediate lymphocytic lymphoma: Clinical and patological features of a recntly characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 11:802, 1993
12. Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F: Patterns of survival in mantle cell lymphoma. Ann Oncol 6:257, 1993
13. Teodorovic IT, Pittaluga S, Kluin-Nelemans JC, Meerwaldt JH, Hagenbeek A, van Glabbek M, Somers R, Bijnens L, Noordijk EM, De Wolf Peeters C: Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin lymphoma subtypes. J Clin Oncol 13:2819, 1995
14. Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Nadler LM: Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 77:2524, 1991
15. Rohatiner AZS, Johnson PWM, Price CGA, Arnott SJ, Amess JAL, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J, MacCallum PK, Oza AM, Lister TA: Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Ann Oncol 5:143, 1994 (suppl 2)
16. Armitage JO: Bone marrow transplantation for indolent lymphomas. Semin Oncol 20:136, 1993
17. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet 334:580, 1989
18. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211, 1991
19. Sheridan WP, Begley CG, Juttner C, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotehrapy. Lancet 1:640, 1992
20. Pettengell R, Nydia G, Swindell R, Crowther D, Dexter TM: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239, 1993
21. Haas R, Moos M, Mohle R, Dohner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W: High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 17:149, 1996
22. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau JP, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B: Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257, 1995
23. Tarella C, Gavarotti P, Caracciolo D, Corradini P, Cherasco C, Castellino C, Pileri A: Haematological support of high-dose sequential chemotherapy: Clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas. Ann Oncol 6:3, 1995
24. Kessinger A, Vose JM, Bierman PJ, Armitage JO: High-dose therapy and autologous peripheral blood stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: An alternative to bone marrow purging. Exp Hematol 19:1013, 1991
25. Hardingham JE, Kotasek D, Sage RE, Dobrovic A, Gooley T, Dale BM: Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 11:15, 1993
26. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
27. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, Pileri A: High-dose sequential chemoradiotherapy in multiple myeloma: Residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 85:1596, 1995
28. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow tranplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
29. Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
30. Tsujimoto Y, Finger LR, Yunis J, Norwell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science 226:1097, 1984
31. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 81:593, 1985
32. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA: Detection of minimal residual disease carrying the t(14; 18) by DNA sequence amplification. Science 237:175, 1987
33. Alt FW, Blackwell TK, Yancopoulos GD: Development of the primary antibody repertoire. Science 238:1079, 1987
34. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
35. Tarella C, Caracciolo D, Gavarotti P, Bondesan P, Cherasco C, Omedè P, Bregni M, Siena S, Gianni AM, Pileri A: Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: Short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 16:223, 1995
36. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
37. Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237, 1989
38. Corradini P, Boccadoro M, Voena C, Pileri A: Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG)-and (IgA)-secreting multiple myelomas. J Exp Med 178:1091, 1993
39. Lin F, Cross NCP: Molecular methods for monitoring malignant disease after bone marrow transplantation. Curr Opin Hematol 2:460, 1995
40. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
41. Tarella C, Boccadoro M, Omedè P, Bondesan P, Caracciolo D, Frieri R, Bregni M, Siena S, Gianni AM, Pileri A: Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant 11:271, 1993
42. Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Fruhauf S, Flentje M, Wannenmacher M, Hunstein W: Sequential high-dose therapy with peripheral-blood progenitor-cell support in low grade non-Hodgkin's lymphoma. J Clin Oncol 12:1685, 1994
43. Hardingham JE, Kotasek D, Sage RE, Gooley LT, Mi JX, Dobrovic A, Norman JE, Bolton AE, Dale BM: Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 13:1073, 1995
44. Yan Y, Chan WC, Weisenburger DD, Anderson JR, Bast MA, Vose JM, Bierman PJ, Armitage JO: Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol 13:1336, 1995
45. Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Schuuring E, Kramer MHH, van Deijk WA, Rahder JB, Kluin PM, Van Krieken JHJM: Mantle-cell lymphoma: A population-based clinical study. J Clin Oncol 14:1269, 1996
46. Janssen WE: Peripheral blood and bone marrow hematopoietic stem cells: Are they the same? Semin Oncol 20:19, 1993
47. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647, 1995
48. Dreger P, von Neuhoff N, Suttorp M, Loffler H, Schmitz N: Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads. Bone Marrow Transplant 16:627, 1995